Phosphorus is a well-known genomics firm with its headquarters in New York City its main laboratory is in Secaucus, New Jersey. The company recently announced that the US Food and Drug Administration (FDA) has honored its Emergency Use Authorization request, allowing for their saliva test for COVID-19. This test features a home use sample collection.
Many people can be tested in the comfort of their homes, allowing for the situation to defuse as the sick can get early treatment while those who are not sick can go on with life as normal. Phosphorus Diagnostics’ approval by the federal government followed a rigorous round of validation studies. This is a major achievement considering that it is the second home-based test approved by the FDA so far.
Using Phosphorus Genomics’ Solution
Compared to the swab-based test method, the saliva test is simpler and less intrusive. The ease of use of this test is a major step toward curbing the spread of the COVID-19 pandemic. The method allows for repeated testing protocols, meaning that it is now easiest to contain the spread of the virus.
Ordering the Saliva Test
To order the home test, consumers can follow the steps below:
- Choose and order the test through the online checkout process.
- Complete the medical questionnaire.
- As an independent physician examines and reviews the medical information you submitted.
- Upon approval, a sample collection kit is sent to your home.
- The test results will then be available 72 hours from when the laboratory receives them. The results will be accompanied by a relevant consultation from the medical team.
Phosphorus has partnered with several health facilities to ensure that more tests are being carried out while minimizing the risk of exposure, since these samples are taken at home.
This method of COVID testing is geared towards helping get things back to normal. The fact that people can be tested in the comfort of their own homes allows things to slowly improve, as the sick can get early treatment while those who are not sick can go on with life as normal. The CEO of Phosphorus, Alexander Bisignano, has expressed his gratitude to the FDA for tirelessly working to ensure that this quick solution became available for use. He went on to say that he was excited about the possibility of reopening the country through these measures.
The testing protocols at Phosphorus are strict to ensure accurate and reliable results after the tests are done. The company’s in-depth clinical trials guarantee a safe test kit since they are going beyond the bare minimum authorized by the FDA. Having complied fully with the FDA’s Guidelines for Diagnostic Tests for Coronavirus Disease-2019, the tests are now being developed at Phosphorus’s CLIA laboratory in Secaucus, NJ.
This method of using a saliva collection device has proven to be more stable and reliable than other techniques. After a series of Phosphorus Diagnostics tests, Phosphorus Genomics’ expertise guarantees reliable testing by offering the next-generation sequencing (NGS) technologies needed by health facilities. This is the future of testing in the medical world. The Phosphorus laboratory is authorized to operate in all 50 states in the US, shifting its focus to COVID-19 testing as a way of realizing methods to help fix the current health crisis. Phosphorus has chosen to partner with BioIQ in its endeavors.
About Phosphorus
Phosphorus is a company that specializes in improving human health by harnessing and understanding the human genome. It achieves its goals through a high-quality, comprehensive, and cost-effective genetic testing portfolio. This company is making it possible for many people to access quality care with its genetic testing in different fields. These tests focus on fertility, lipidology, cardiology, oncology, neurology, pharmacogenetics, pediatric and metabolic disorders, and ophthalmology. These comprehensive tests make it possible for specific treatment approaches to be carried out successfully.
